Toggle navigation
Home
Search
Services
Blog
Contact
About
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M.
Redox Pharmaceutical Corporation, Greenvale, NY, United States
Search 21 grants from Richard Burger
Search grants from Redox Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Modeling Inherited Neurodevelopmental Disorders with Human Induced Pluripotent Stem Cells
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome
Bone Cell Regulation of the Vitamin D Receptor Gene
Melanoma Vaccines with Peptides, Protein and Adjuvant
Statistical Methods in AIDS Research
Recently added grants:
Patient-Oriented Research on Pseudomonas aeruginosa
Novel platform for research brain banking and characterization using integrated traditional and quantitative analyses to promote precision neuropathology of Alzheimer's disease
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
Adapting Advance Care Planning Tools for Permanent Supportive Housing Residents
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44EY011724-02
Application #
2165895
Study Section
Special Emphasis Panel (ZRG1-SEN (02))
Project Start
1996-09-01
Project End
1998-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Redox Pharmaceutical Corporation
Department
Type
DUNS #
City
Greenvale
State
NY
Country
United States
Zip Code
11548
Related projects
NIH 1997
R44 EY
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M. / Redox Pharmaceutical Corporation
NIH 1996
R44 EY
New Therapy for Ocular Herpes Simplex Keratitis
Burger, Richard M. / Redox Pharmaceutical Corporation
Publications
Asbell, P A; Epstein, S P; Wallace, J A et al.
(1998)
Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Cornea 17:550-7
Comments
Be the first to comment on Richard Burger's grant